Diabetic Nephropathy Market to Grow at a Substantial Growth Rate by 2032, Assesses DelveInsight |Key Players in the Market - Prokidney, Inversago, Palatin Technologies, Lexicon, Daiichi Sankyo, CSL Behring
07 nov. 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Diabetic Nephropathy Market to Grow at a Substantial Growth Rate by 2032, Assesses DelveInsight |Key Players in the Market - Prokidney, Inversago,...
European Patent Office to Grant ZyVersa Therapeutics’ Patent Application for Cholesterol Transport Mediator™ VAR 200 for Use in Patients with Diabetic Nephropathy/Diabetic Kidney Disease
06 juin 2023 09h07 HE
|
ZyVersa Therapeutics
Cholesterol Transport Mediator™ VAR 200 is in development to reduce renal cholesterol and lipid accumulation that damages the kidneys' filtration system in patients with glomerular diseases, including...
Diabetic Nephropathy Market Size Expected to Reach USD 3.34 Billion by 2028, at a 4.3% CAGR
09 mars 2023 07h39 HE
|
Fortune Business Insights
Pune, India, March 09, 2023 (GLOBE NEWSWIRE) -- The global diabetic nephropathy market size was valued at USD 2.38 billion in 2020. The market is estimated to rise from USD 2.49 billion in 2021 to...
Diabetic Nephropathy Market Size Worth USD 3.43 Billion by 2030 at 6.20% CAGR – Report by Market Research Future (MRFR)
22 févr. 2023 09h00 HE
|
Market Research Future
New York, USA, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Diabetic Nephropathy Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), The Diabetic Nephropathy...
Diabetic Nephropathy Market Is Expected to Reach $3.3 Billion by 2031, Says AMR
13 juil. 2022 08h28 HE
|
Allied Market Research
Portland, OR, July 13, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global diabetic nephropathy market was estimated at $1.9 billion in 2021 and is...
Diabetic Nephropathy Market Size [2022-2028] worth USD 3.34 Billion | exhibiting a CAGR of 4.3%
22 mars 2022 09h05 HE
|
Fortune Business Insights
Pune, India, March 22, 2022 (GLOBE NEWSWIRE) -- The global diabetic nephropathy market size was valued at USD 2.38 billion in 2020. The market is estimated to rise from USD 2.49 billion in 2021 to...
Diabetic Nephropathy Market Report 2021-2028 | Size, Share, Growth, Trends, Competitive Landscape, Revenue, Analysis, Forecast Report
20 juil. 2021 05h56 HE
|
Fortune Business Insights
Pune, India, July 20, 2021 (GLOBE NEWSWIRE) -- The increasing prevalence of diabetes around the world is expected to spur opportunities for the market during the forecast period, states Fortune...
Cyclerion Updates Corporate Progress
10 avr. 2020 07h00 HE
|
Cyclerion Therapeutics, Inc.
– Closed enrollment for olinciguat Phase 2 STRONG SCD study for sickle cell disease; topline data readout expected Q3 2020 – – Closed enrollment for IW-6463 translational pharmacology...
Cyclerion announces IW-6463 phase 1 healthy volunteer study results that support further development for neurodegenerative diseases
13 janv. 2020 07h00 HE
|
Cyclerion Therapeutics, Inc.
– Results in 110 subjects demonstrate favorable safety, CNS pharmacokinetics, and evidence of target engagement – – Study underway in elderly subjects to further assess cerebral blood flow and...
Cyclerion to Present at the J.P. Morgan Healthcare Conference
23 déc. 2019 07h00 HE
|
Cyclerion Therapeutics, Inc.
– Management to review the Company's sGC clinical pipeline programs: praliciguat for diabetic nephropathy, olinciguat for sickle cell disease, and IW-6463 for neurodegenerative diseases – CAMBRIDGE,...